XFOR- X4 Pharmaceuticals, Inc

Name: X4 Pharmaceuticals, Inc Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

X4 Pharmaceuticals, Inc (XFOR) has 11 insiders with recent SEC Form 4 filings, including 0 buys and 11 sells. XFOR is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
Other	Craig Adam R	2.33M	$10.34M	-
Pres	Volpone John	2.33M	$10.34M	-
CFO	Kirske David	1.55M	$6.89M	-
Other	Baldry Mark	25.3K	$112.5K	-
Other	Thoren Natasha Fay	9.5K	$42.0K	-

Activity

Buys and sells only

Transactions

10 filings · page 3

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Feb 12, 2024	Dibiase Mary71	Chief Operating Officer	Sell	3,683	$1.01	$3,708.78	-1.2%	-4.3%	-54.0%
Feb 12, 2024	Taveras Arthur63	Chief Scientific Officer	Sell	787	$1.01	$792.67	-0.3%	-4.3%	-54.0%
Feb 12, 2024	Ragan Paula77	President And CEO	Sell	21,695	$1.01	$21,892.42	-2.6%	-4.3%	-54.0%
Feb 12, 2024	Mostafa Adam S.75	Chief Financial Officer	Sell	27,721	$1.01	$27,973.26	-34.6%	-4.3%	-54.0%
Nov 3, 2023	Ragan Paula77	President And CEO	Sell	239,437	$0.76	$181,573.03	-12.3%	-11.2%	-45.1%
Nov 1, 2023	Mostafa Adam S.75	Chief Financial Officer	Sell	230,645	$0.73	$168,370.85	-74.2%	+6.8%	-33.4%
Nov 1, 2023	Dibiase Mary71	Chief Operating Officer	Sell	67,695	$0.73	$49,417.35	-17.9%	+6.8%	-33.4%
Nov 1, 2023	Baldry Mark56	Chief Commercial Officer	Sell	10,257	$0.73	$7,487.61	-29.4%	+6.8%	-33.4%
Nov 1, 2023	Taveras Arthur63	Chief Scientific Officer	Sell	67,695	$0.73	$49,417.35	-21.4%	+6.8%	-33.4%
Sep 8, 2023	Dibiase Mary71	Chief Operating Officer	Sell	2,642	$1.25	$3,299.86	-1.8%	-26.1%	-46.6%

← PrevPage 3Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC